INS and obesity disorder: Inflammation disrupts the effectiveness of insulin, and this insulin resistance and subsequent glucose and fat accumulation in the liver underpin the link between higher inflammation and obesity, as indexed by higher measures of adiposity (i.e., higher LAP).